Medical Weight Loss for Roswell, Georgia Residents

Roswell, Georgia residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Roswell through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

No clinic to drive to in Roswell: Dr. Anjmun Sharma reviews your health by video, and your compounded semaglutide or tirzepatide ships straight to your Georgia address. Nothing to pick up, no waiting room, no local office needed. Doctor review just $119 (medication separate).

Why Roswell Residents Choose New Hope Weight Loss

Some patients in Roswell are weighing semaglutide against tirzepatide, and that is a conversation worth having with a doctor, not a website. Dr. Anjmun Sharma helps you understand the trade-offs, the cost difference between $166 and $233 a month, and what the trial data actually showed, with semaglutide averaging about 15 to 17 percent body-weight loss and tirzepatide reaching up to 22.5 percent at qualifying doses. These are compounded, not brand-identical, and results vary, so the choice should be informed.

From our Costa Mesa, California practice, we provide Roswell with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

There is no New Hope Weight Loss office in Roswell, and there does not need to be, since the same doctor-led program is delivered to every corner of Georgia through telehealth visits. We care for patients throughout the greater Roswell area and north metro Atlanta. Because everything happens by telehealth, patients across the greater Roswell area and north metro Atlanta get the same physician-led program without driving anywhere or sitting in a waiting room.

Treatment is supervised by the same physician for all of Georgia, which means your distance from Costa Mesa changes nothing about your care or your cost. If you and Dr. Sharma decide tirzepatide fits your goals, Roswell patients can begin from $233 per month, billed apart from your initial $119 visit. New Hope Weight Loss reaches patients all across fast-growing Georgia by secure telehealth from our Costa Mesa, California clinic, with no local office and no need to travel.

GLP-1 Weight Loss Programs Available

The 90-Day Metabolic Reset (Semaglutide)

Think of this as a focused three-month plan. Semaglutide carries the same active ingredient as Wegovy and Ozempic, and the branded versions averaged about 15 to 17 percent body-weight loss in trials. Pricing is from $166/mo, with the full 90 days at $499, and Dr. Sharma adjusts your dose along the way. Compounded semaglutide is not FDA-approved, not brand-identical, and individual results vary.

Advanced Program (Tirzepatide)

From $233/mo, tirzepatide engages two metabolic pathways, GLP-1 and GIP. Trials of the branded drug reached up to 22.5 percent loss at higher qualifying doses, a best-case figure rather than the norm. Shares an active ingredient with Mounjaro and Zepbound.

Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm welcome for Roswell telehealth patients.

How Telehealth Works for Roswell

Starting care with us looks nothing like a traditional doctor visit. There is no office to find and no drive across Roswell. You complete an online intake quiz covering your health background and weight goals, and Dr. Anjmun Sharma reviews it personally. She then meets you by secure video, typically within 48 hours, to decide together whether compounded semaglutide or tirzepatide is appropriate. If it is, a state-licensed 503(a) pharmacy ships your medication to your Roswell address in cold-pack packaging that protects it in transit, and all of your follow-ups happen by video so your plan keeps moving wherever you are in .

Frequently Asked Questions, Roswell

I am searching for weight loss care near Roswell. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in Roswell, Georgia connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in Roswell?

Not at all. The telehealth format covers Roswell patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to Roswell in cold-pack packaging built to keep it cool and stable.

What are the program costs for Roswell patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and Roswell patients face no distance surcharge.

What areas of Roswell do you serve?

We serve patients from across Roswell by telehealth, including the greater Roswell area and north metro Atlanta.

Who qualifies for the program in Roswell?

Eligibility for Roswell patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.

Roswell Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Roswell, Georgia by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.